SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-000302
Filing Date
2022-01-04
Accepted
2022-01-04 16:06:16
Documents
81
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1715745
2 ex4-2.htm EX-4.2 60912
3 ex10-8.htm EX-10.8 13467
4 ex23-1.htm EX-23.1 4672
5 ex31-1.htm EX-31.1 16771
6 ex31-2.htm EX-31.2 16883
7 ex32-1.htm EX-32.1 6923
8 ex32-2.htm EX-32.2 6813
9 ex10-8_001.jpg GRAPHIC 648949
10 ex10-8_002.jpg GRAPHIC 587459
11 ex10-8_003.jpg GRAPHIC 623767
12 ex10-8_004.jpg GRAPHIC 733000
13 ex10-8_005.jpg GRAPHIC 763006
14 ex10-8_006.jpg GRAPHIC 713395
15 ex10-8_007.jpg GRAPHIC 752550
16 ex10-8_008.jpg GRAPHIC 663792
17 ex10-8_009.jpg GRAPHIC 544432
18 ex10-8_010.jpg GRAPHIC 584449
19 ex10-8_011.jpg GRAPHIC 722564
20 ex10-8_012.jpg GRAPHIC 661677
21 ex10-8_013.jpg GRAPHIC 664169
22 ex10-8_014.jpg GRAPHIC 191805
23 ex10-8_015.jpg GRAPHIC 414529
24 ex10-8_016.jpg GRAPHIC 339150
  Complete submission text file 0001493152-22-000302.txt   20566180

Data Files

Seq Description Document Type Size
25 XBRL SCHEMA FILE anix-20211031.xsd EX-101.SCH 37811
26 XBRL CALCULATION FILE anix-20211031_cal.xml EX-101.CAL 49830
27 XBRL DEFINITION FILE anix-20211031_def.xml EX-101.DEF 173230
28 XBRL LABEL FILE anix-20211031_lab.xml EX-101.LAB 358326
29 XBRL PRESENTATION FILE anix-20211031_pre.xml EX-101.PRE 274280
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1431886
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-37492 | Film No.: 22505824
SIC: 2834 Pharmaceutical Preparations